Hepatic IRF2BP2 Mitigates Nonalcoholic Fatty Liver Disease by Directly Repressing the Transcription of ATF3-Reference-Cited by-同舟云学术

Hepatic IRF2BP2 Mitigates Nonalcoholic Fatty Liver Disease by Directly Repressing the Transcription of ATF3

Published:2020-01-30 Issue:5 Volume:71 Page:1592-1608
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Fang Jing¹²³,Ji Yan‐Xiao⁴⁵,Zhang Peng⁴⁵,Cheng Lin¹²³,Chen Yue¹²³,Chen Jun¹²³,Su Yanfang⁵,Cheng Xu⁶,Zhang Yan⁶,Li Tianyu⁷,Zhu Xuehai¹²³,Zhang Xiao‐Jing⁶⁵,Wei Xiang¹²³

Affiliation:

1. Division of Cardiothoracic and Vascular Surgery Tongji Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China

2. Key Laboratory of Organ Transplantation Ministry of Education Tongji Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China

3. Key Laboratory of Organ Transplantation Ministry of Health Tongji Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China

4. Medical Science Research Center Zhongnan Hospital of Wuhan University Wuhan China

5. Institute of Model Animals of Wuhan University Wuhan China

6. Department of Cardiology Renmin Hospital of Wuhan University Wuhan China

7. Trauma Center/Department of Emergency and Trauma Surgery, Tongji Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.30950

Reference41 articles.

1. Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease

2. Mechanisms of NAFLD development and therapeutic strategies

3. Identification of novel co-repressor molecules for Interferon Regulatory Factor-2